Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Elanco Animal Health Inc’s stock clocked out at $9.38, up 12.61% from its previous closing price of $8.33. In other words, the price has increased by $12.61 from its previous closing price. On the day, 12.5 million shares were traded. ELAN stock price reached its highest trading level at $9.5 during the session, while it also had its lowest trading level at $8.03.
Ratios:
To gain a deeper understanding of ELAN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.82. For the most recent quarter (mrq), Quick Ratio is recorded 1.25 and its Current Ratio is at 2.44. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on December 09, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On December 02, 2024, Leerink Partners started tracking the stock assigning a Market Perform rating and target price of $14.
Morgan Stanley Downgraded its Overweight to Equal-Weight on September 19, 2024, whereas the target price for the stock was revised from $17 to $15.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when Kurzius Lawrence Erik bought 10,000 shares for $10.90 per share. The transaction valued at 109,000 led to the insider holds 101,459 shares of the business.
Kurzius Lawrence Erik bought 10,000 shares of ELAN for $102,000 on Mar 11 ’25. The Director now owns 111,459 shares after completing the transaction at $10.20 per share. On Mar 05 ’25, another insider, HOOVER R DAVID, who serves as the Director of the company, bought 25,000 shares for $10.90 each. As a result, the insider paid 272,558 and bolstered with 210,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELAN now has a Market Capitalization of 4656776192 and an Enterprise Value of 8501717504. As of this moment, Elanco’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.82, and their Forward P/E ratio for the next fiscal year is 9.73. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.05 while its Price-to-Book (P/B) ratio in mrq is 0.76. Its current Enterprise Value per Revenue stands at 1.915 whereas that against EBITDA is 9.672.
Stock Price History:
The Beta on a monthly basis for ELAN is 1.50, which has changed by -0.3640678 over the last 52 weeks, in comparison to a change of 0.049593568 over the same period for the S&P500. Over the past 52 weeks, ELAN has reached a high of $18.80, while it has fallen to a 52-week low of $8.19. The 50-Day Moving Average of the stock is -13.61%, while the 200-Day Moving Average is calculated to be -26.64%.
Shares Statistics:
It appears that ELAN traded 4.82M shares on average per day over the past three months and 6634920 shares per day over the past ten days. A total of 494.45M shares are outstanding, with a floating share count of 491.74M. Insiders hold about 0.95% of the company’s shares, while institutions hold 99.41% stake in the company. Shares short for ELAN as of 1741910400 were 14658581 with a Short Ratio of 3.04, compared to 1739491200 on 15226786. Therefore, it implies a Short% of Shares Outstanding of 14658581 and a Short% of Float of 4.75.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
